MEDISIEVE LTD

Active London

Other research and experimental development on natural sciences and engineering

6 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
M

MEDISIEVE LTD

Other research and experimental development on natural sciences and engineering

Founded 8 Apr 2014 Active London, England 6 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
Accounts Submitted 16 Feb 2026 Next due 30 Jun 2026 2 months remaining
Confirmation Submitted 15 Apr 2026 Next due 22 Apr 2027 12 months remaining
Net assets £438K £26K 2025 year on year
Total assets £2M £271K 2025 year on year
Total Liabilities £1M £245K 2025 year on year
Charges 4
2 outstanding 2 satisfied

Contact & Details

Contact

Registered Address

Keystone Law 48 Chancery Lane London WC2A 1JF England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for MEDISIEVE LTD (08983823), an active life sciences and medical technology company based in London, England. Incorporated 8 Apr 2014. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2015–2025)

Cash in Bank

£515.00k

Increased by £434.76k (+542%)

Net Assets

£437.57k

Increased by £26.12k (+6%)

Total Liabilities

£1.14M

Increased by £245.05k (+27%)

Turnover

N/A

Employees

6

Decreased by 1 (-14%)

Debt Ratio

72%

Increased by 3 (+4%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3
Grants 4

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 5Jun 2018Series A, Seed

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 947,004 Shares £3.04m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
16 Oct 202514,560£145.6£0.01
6 Jun 2025877,873£2.31m£2.631
5 Apr 201854,571£731k£13.404

Officers

Officers

3 active
Status
Frodsham, George Charles MartinDirectorBritishFrance398 Apr 2014Active
Jones, Christopher MichaelDirectorAmericanEngland599 Nov 2015Active
Salem, GabyDirectorBelgianEngland5420 Dec 2017Active

Shareholders

Shareholders (23)

24haymarket Nominees Limited
24.6%
George Frodsham
24.1%

Persons with Significant Control

Persons with Significant Control (2)

2 Active 4 Ceased

George Charles Martin Frodsham

British

Active
Notified 6 Apr 2016
Residence England
DOB January 1987
Nature of Control
  • Significant Influence Or Control

Dr George Charles Martin Frodsham

British

Active
Notified 6 Apr 2016
Residence France
DOB January 1987
Nature of Control
  • Significant Influence Or Control

Gaby Salem

Ceased 21 Jan 2021

Ceased

Chris Jones

Ceased 21 Jan 2021

Ceased

Marek Stefan Gumienny

Ceased 21 Jan 2021

Ceased

Quentin Andrew Pankhurst

Ceased 21 Jan 2021

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

2 outstanding 2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
15 Apr 2026Confirmation StatementConfirmation statement made on 2026-04-08 with updates
16 Feb 2026AccountsAnnual accounts made up to 2025-09-30
11 Feb 2026CapitalAllotment of shares (GBP 12,572.27) on 2025-10-16
5 Feb 2026MiscellaneousReplacement filing of SH01 - 06/06/25 Statement of Capital gbp 12426.67
9 Jan 2026MortgageMortgage Create With Deed With Charge Number Charge Creation Date
15 Apr 2026 Confirmation Statement

Confirmation statement made on 2026-04-08 with updates

16 Feb 2026 Accounts

Annual accounts made up to 2025-09-30

11 Feb 2026 Capital

Allotment of shares (GBP 12,572.27) on 2025-10-16

5 Feb 2026 Miscellaneous

Replacement filing of SH01 - 06/06/25 Statement of Capital gbp 12426.67

9 Jan 2026 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

Recent Activity

Latest Activity

Confirmation statement made on 2026-04-08 with updates

4 days ago on 15 Apr 2026

Annual accounts made up to 2025-09-30

2 months ago on 16 Feb 2026

Allotment of shares (GBP 12,572.27) on 2025-10-16

2 months ago on 11 Feb 2026

Replacement filing of SH01 - 06/06/25 Statement of Capital gbp 12426.67

2 months ago on 5 Feb 2026

Mortgage Create With Deed With Charge Number Charge Creation Date

3 months ago on 9 Jan 2026